Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
European Urology|April 7, 2007
Re: Nomograms provide improved accuracy for predicting survival after radical cystectomyPeter C Black, Colin P Dinney
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
The molecular, the bad, and the ugly: preventing bladder cancer via mTOR inhibitionDavid J McConkey, Colin P Dinney
European Urology|December 10, 2009
Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7Robert S Svatek, Colin P Dinney
Expert Review of Anticancer Therapy|June 6, 2009
Novel therapeutics for patients with non-muscle-invasive bladder cancerRobert S Svatek, Ashish M Kamat, Colin P Dinney
Current Opinion in Urology|August 10, 2004
Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE)Ralph A Highshaw, David J McConkey, Colin P Dinney
Expert Review of Anticancer Therapy|April 13, 2023
The current status of gene therapy in bladder cancerCôme Tholomier, Alberto Martini, Sharada Mokkapati, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapyRobert S Svatek, Arlene Siefker-Radtke, Colin P Dinney
Current Opinion in Urology|August 15, 2006
Should cystectomy only be performed at high-volume hospitals by high-volume surgeons?Peter C Black, Gordon A Brown, Colin P Dinney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancerPeter C Black, Gordon A Brown, Colin P Dinney
Pharmacogenomics|September 7, 2005
The pharmacogenetic impact of inflammatory genes on bladder cancer recurrenceJian Gu, H Barton Grossman, Colin P Dinney, et al.
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
European Urology|April 7, 2007
Re: Nomograms provide improved accuracy for predicting survival after radical cystectomyPeter C Black, Colin P Dinney
Cancer Prevention Research (Philadelphia, Pa.)|December 3, 2009
The molecular, the bad, and the ugly: preventing bladder cancer via mTOR inhibitionDavid J McConkey, Colin P Dinney
European Urology|December 10, 2009
Words of wisdom. Re: Impact of risk factors on the performance of the nuclear matrix protein 22 point-of-care test for bladder cancer detection. Lotan Y, Shariat SF; NMP22 Study Group. BJU Int 2008;101:1362-7Robert S Svatek, Colin P Dinney
Expert Review of Anticancer Therapy|June 6, 2009
Novel therapeutics for patients with non-muscle-invasive bladder cancerRobert S Svatek, Ashish M Kamat, Colin P Dinney
Current Opinion in Urology|August 10, 2004
Integrating basic science and clinical research in bladder cancer: update from the first bladder Specialized Program of Research Excellence (SPORE)Ralph A Highshaw, David J McConkey, Colin P Dinney
Expert Review of Anticancer Therapy|April 13, 2023
The current status of gene therapy in bladder cancerCôme Tholomier, Alberto Martini, Sharada Mokkapati, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 19, 2009
Management of metastatic urothelial cancer: the role of surgery as an adjunct to chemotherapyRobert S Svatek, Arlene Siefker-Radtke, Colin P Dinney
Current Opinion in Urology|August 15, 2006
Should cystectomy only be performed at high-volume hospitals by high-volume surgeons?Peter C Black, Gordon A Brown, Colin P Dinney
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2006
Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancerPeter C Black, Gordon A Brown, Colin P Dinney
Pharmacogenomics|September 7, 2005
The pharmacogenetic impact of inflammatory genes on bladder cancer recurrenceJian Gu, H Barton Grossman, Colin P Dinney, et al.
Pageof 21